Shares of Sun Pharmaceutical Industries fell by -0.74% (Rs. 970.05) at closing today at BSE. Today 0.16 Lac shares of the company were traded at BSE. At the current price, its market cap amounts to Rs. 2,34,571.0 Cr approximately.
Sun Pharmaceutical Industries shares have been trading in the price band of Rs. 968.3 and Rs. 978.5 at BSE today. At the day's low, its shares fell by -0.99% as compared to the previous close recorded of Rs. 977.28.
Benchmark indices Sensex (-0.69%) & Nifty (-0.77%) performed poorly at closing today. Sun Pharmaceutical Industries outperformed both of them.
Amongst its peers, Dr Reddys Laboratories rose 0.33%, Cipla was also up 0.86% and Aurobindo Pharma as well had a rise of 2.89% today.
Updated on 14 Nov 2026, 11:37 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Divi's Laboratories | 11,489.65 | 0.35 | 3,05,014.10 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,662.15 | -1.20 | 1,77,326.86 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,393.00 | -1.21 | 1,12,534.68 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,191.00 | -1.20 | 1,18,802.71 | 21.19 | 4.24 | 0.09 | 14.22 |
| Lupin | 1,980.00 | -1.69 | 90,538.64 | 19.12 | 4.98 | 0.74 | 9.53 |
| Meeting Date | Purpose |
|---|---|
| 2026-10-30 | Quarterly Results |
| 2026-10-12 | Others |
| 2026-07-31 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-01-31 | Quarterly Results & Interim Dividend |
Sun Pharmaceutical Industries is trading at 1880.90 as on Fri Nov 13 2026 10:20:13. This is -0.31% lower as compared to its previous closing price of 1886.80.
The market capitalization of Sun Pharmaceutical Industries is 451290.91 Cr as on Fri Nov 13 2026 10:20:13.
The average broker rating on Sun Pharmaceutical Industries is Buy. The breakup of analyst rating is given below -
The 52 wk high for Sun Pharmaceutical Industries is 2047.55 whereas the 52 wk low is 1583.60
Sun Pharmaceutical Industries can be analyzed on the following key metrics -
Sun Pharmaceutical Industries reported a net profit of 11479.42 Cr in 2026.
The Mutual Fund Shareholding was 13.01% at the end of 30 Sep 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.